chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hands are tingling; Hands cold; little bit of tightness in her chest; a lot of bowel movements; dizziness; short of breath; headaches; body aches; chills; fever (hot n cold); This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (hands are tingling), PERIPHERAL COLDNESS (Hands cold), CHEST DISCOMFORT (little bit of tightness in her chest), FREQUENT BOWEL MOVEMENTS (a lot of bowel movements) and DIZZINESS (dizziness) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for an unknown indication.    On 22-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced HEADACHE (headaches), MYALGIA (body aches), CHILLS (chills) and PYREXIA (fever (hot n cold)). On 28-May-2021, the patient experienced PARAESTHESIA (hands are tingling), PERIPHERAL COLDNESS (Hands cold), CHEST DISCOMFORT (little bit of tightness in her chest), FREQUENT BOWEL MOVEMENTS (a lot of bowel movements), DIZZINESS (dizziness) and DYSPNOEA (short of breath). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at a dose of 1 dosage form and BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) for Adverse event, at a dose of 1 dosage form. On 24-May-2021, HEADACHE (headaches), MYALGIA (body aches), CHILLS (chills) and PYREXIA (fever (hot n cold)) had resolved. On 28-May-2021, CHEST DISCOMFORT (little bit of tightness in her chest) had resolved. At the time of the report, PARAESTHESIA (hands are tingling), PERIPHERAL COLDNESS (Hands cold), FREQUENT BOWEL MOVEMENTS (a lot of bowel movements), DIZZINESS (dizziness) and DYSPNOEA (short of breath) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Concomitant medication and treatment medications updated.
Double vaccinated and post Covid 19 (between 1st & 2nd  doses).; Double vaccinated and post Covid 19 (between 1st & 2nd  doses).; This is a spontaneous report from a contactable consumer (patient). This 72-year-old male patient received the 1st dose of bnt162b2 (Pfizer-BioNTech COVID-19 vaccine) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications were unknown. The patient was double vaccinated and post Covid 19 (between 1st & 2nd doses). He was interested in a clinical trial. Outcome of the event was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
TC from mother of client on 6/30/09. Pt received shots 6/29/09 and hasn't slept much - cat naps off and on. Can't get fever under control. Mom called baby's PMD who advised on fever reducer, cool bath and has an appt in AM. Instructed to take to Urgent Care or ER if worse in meantime. 7/1/09 TC to mom. Took to ER Tues nite. Infant was dehydrated and feverish. Was treated with MOTRIN and mom gave Pedialyte to drink in ER. Was to F/U with PMD if necessary. 7/2/09 TC to mom. Baby doing better. Had called PMD to give report. To take to ER or Urgent Care if concerned. 7/6/09 TC to mom. Baby is fine. No fever product given since 7/3/09. Informed mother I would be submitting a VAERS as client was taken in to ER.
Cluster of four patients (gender and age not reported) whose medical history and concomitant medications were not reported; had received MENACTRA Sanofi Pasteur Ltd, (batch number U4344AA, route and site of administration were not reported). Out of the four, three patients also received ADACEL Sanofi Pasteur ltd. (batch number U4384AA route and site of administration were not reported) and one out of the four patients GARDASIL (Manufacturer: Merck, batch number, route and site of administration were not reported) on an unspecified date. On unspecified date, the patients experienced dizziness and nausea within 15 minutes of vaccination. One of the patients was treated with fluids at facility with no relief and was transferred to emergency room of the hospital. The patient's outcome was unknown. Documents held by sender: None.
The patient has experienced lingering arm and muscle pain in the vaccinated arm. There is also numbness/tingling in three fingers of the same hand.
Pt recvd 3 doses of Engerix-B, 3rd dose given 18OCT90 &  was determined that pt had a borderline Hep B titer; Booster dose was given 29DEC90 & it was again determined that titer was borderline; Reporter indicated that 5th dose may be given;
I start having brain fog, difficulty with small motor control. I couldn't button my shirt. Overall weakness. I saw a neuro doctor and he order an MRI and they saw brain lesions and swelling. They did a brain biopsy 04/04/2021 and they was looking for cancer. The results was inconclusive. The did a second biopsy on 05/20/2021, they sent samples, no cancer was detect in the sample but it shows abnormal tissues. Now just waiting to see another doctor because they don't know what is causing the lesions.
On 3/4. I developed a 1 inch fevered hot oval at injection site.  It was sore and itchy. It began getting bigger and bigger with fever into the newly expanding area.  Went to the doctor on 3/8/21, and Dr. thought that it was cellulitis.  He put me on Cephalexin 250 mg 3 times per day for 7 days.  It is still there, but lighter in color on  3/11/21.  I return to have it rechecked at doctors office tomorrow.
On an unknown date the patients were vaccinated with improperly stored ROTATEQ. Strength, dose, route and lot number were not provided. ROTATEQ was exposed to a temperature between 46.5F and a highest of 48F for a total of 45 hours and 5 minutes from 10-APR-2014 to 02-MAY-2014: Out of range for 2 hours from 10-APR-2014 to 11-APR-2014; out of range for 10 hours and 15 minutes on 12-APR-2014; out of range for 12 hours and 25 minutes on 13-APR-2014; out of range for 1.5 hours on 14-APR-2014; out of range for 9.5 hours on 01-MAY-2014; out of range for 9 hours and 25 minutes on 02-MAY-2014. No adverse effects were reported. This is one of several reports received from the same reporter (other case IDs: 1405USA004214, 1405USA004215 and 1405USA002823). Additional information has been requested.
Patient reported feeling dizziness, having ringing in her ears and sweating 3 minutes after vaccination. She also reported having pain in her arm.  She was given water and cool rag to help cool her down.  She also reported not eating since 2pm today so she drank some orange juice and crackers.  After 15 minutes she was feeling better and was able to leave on her own/
Patient went to Urgent Care due to concern about allergic reaction to MMR vaccine administered at Pharmacy. Signs and symptoms are the following: redness and swelling of the face, hands, and nose. His nasal passages are swollen shut. Intense pruritus. Had shortness of breath. The patient was treated with Diphenhyramine 50 mg IM, famotidine 20 mg IV, dexamethasone 10 mg IV, and epinephrine 0.3 mg IM. The patient was discharge home.
Sore arm; Some fatigue; Headache; This case was reported by a consumer via other manufacturer and described the occurrence of pain in arm in a patient who received DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis.   On an unknown date, the patient received Tdap Vaccine. On an unknown date, unknown after receiving Tdap Vaccine, the patient experienced pain in arm, fatigue and headache. On an unknown date, the outcome of the pain in arm, fatigue and headache were unknown.   It was unknown if the reporter considered the pain in arm, fatigue and headache to be related to Tdap Vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that, they had some issues with lots of vaccines and had sore arm, some fatigue and headache with Tdap vaccine as well. This case has been linked with US2021AMR001161 (Shingrix case) reported by same reporter, same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR001161:Tdap vaccine, same reporter
Patient is a 13 year old female who presents to the clinic today with her mother for a follow up ER visit from 5/30/21. Patients mother reports that patient had received her first Pfizer COVID-19 vaccination on 5/26/21, and developed a headache on Thursday. On Friday, mother and patient report that she had a very active day at school, and in Phy-Ed she did a cardio work out, followed by a 10 minute run and then golf practice after school. Patient reports that she does not frequently go running. Saturday, mom reports that patient was fatigued and rested most of the day. Sunday, she was up at 5am and was working by 6am until noon at the family restaurant. Her mother reports that it was very busy at the restaurant. Later in the afternoon on Sunday, the family went to their lake house in New Auburn, MN. Mother reports that the patient ate a good supper and the patient was asked to take the dog for a walk around 8pm. Patient took the dog for a walk for about 5 minutes, and then came back and went to her room, and her older sister found her lying in her room with her arms flexed and legs extended. Mom reports that she was drooling, staring and her muscles were stiff, and she wouldn't bear weight on her legs. This lasted approximately 10 minutes and she was transferred by ambulance to the Bloomer ER for evaluation. Initial ER workup in Bloomer showed leukocytosis at 11.4, a CK of 333, and an alk phos of 263. Her CBC, Comp, CRP, Lactate, pregnancy, lymes, COVID and UA were all within normal limits. A head CT was negative as well. Given her symptoms, she was transferred from Bloomer ER to St. Mary's in Rochester to the general pediatric floor early Monday morning. Peds neurology consulted and diagnosed her with dissociative (non-epileptic) attack, and discharged her home around 5pm on Monday evening with family. Since discharge, she reports that she is still experiencing fatigue, a mild headache, and her quadricep muscles feel weak and ache. Mom reports that she has been monitored by family since discharge and she has not had another episode since. For pain, she is taking tylenol and ibuprofen with minimal relief. She has started her menses, her onset of menarche was January, 2021, and she did not have a menstrual cycle in February, March or April, and she began her menses on 5/24 through 5/30. Clinic recommends oupatient testing for an EEG, Echo, EKG and MRI and follow up with neurology.
pt recvd vax on 8SEP92 & next day exp sharp pain in the lt side of chest, profuse sweating & difficulty breathing; seen by MD;
I have had a migraine/headache  since I have gotten the second vaccine, also dizzy and light headed, along with vomiting
Paralysis of vocal cords for 39 days. Pt took steroids for decreased swelling of muscles in throat. Voice conts to come and go. Pt conts to flu with ENT.
Had large red rash, swollen left arm very swollen. Hurt to touch, nauseating, headache. Slept for hours. Tremors and itchy red rash at injection site.
Breakthrough COVID-19 case with unknown symptom onset: sob/difficulty breathing, nausea or vomiting, generalized weakness.  Hospitalized 8/9/2021 to 8/16/2021. Death 8/16/2021. COD respiratory arrest, COVID-19. Place of death: HOSPITAL.  CERTIFIED BY PRONOUNCING AND CERTIFYING PHYSICIAN
Flu-like symptoms; Rhabdomyolysis; loss of consciousness; dehydration; This is a spontaneous report from a contactable consumer. A 47-years-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration, administered in left arm on 26Mar2021 at 12:00 (at the age of 47-years old) as single dose for COVID-19 immunisation. The patient received the first dose on 05Mar2021 in arm left (lot number EN6198). Medical history included hypertension and gastrooesophageal reflux disease (GERD). The patient had n known allergy. He did not have COVID prior vaccination and he was not COVID tested post vaccination. Concomitant medications included omeprazole and hydrochlorothiazide/losartan potassium (LOSARTAN HCTZ). The patient experienced flu-like symptoms starting 6-8 hours after shot and continuing into the following day, rhabdomyolysis, loss of consciousness and dehydration. Adverse event start time was reported as 06:30 PM. The patient was hospitalized 3 days in ICU, plus 3 additional days. The events resulted in resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization and life-threatening illness (immediate risk of death from the event). The events were treated with IV Fluids and treatment to raise sodium. The outcome of event was recovering.
About 8 hrs post injection, multiple symptoms started: muschle aches & soreness, chills, shivering, diarrhea, headache.  Symptoms were very intense. It?s been 21 hours & side effects have improved but are still present.
I began experiencing muscle aches, chills, night sweats, shortness of breath, blurred vision, dizziness and a nagging headache about 2 days after the first Moderna injection. These symptoms continued for well over a week but gradually got better each day for over a week. I monitored my body temperature and it was continuously normal and I never lost sense of taste or smell.
Redness chest and back, tightness abdomen, pinch in back feeling. Discussed increase cetirizine to one tab po bid.  Started topical fluocinonide.  Injection was given at 2nd floor injection center. Came for Allergy office appt. 12/14/15.
Redness, swelling, warm to touch for a week. TYLENOL OTC. Still red after a week.
Patient hospitalized for initiation of HD with nephrology within 6 weeks of receiving COVID vaccination.
Vaccine was administered on 1/19/23, which was after the Beyond Use Date of 1/6/23. Individual was notified that shot will need to be repeated.
PGM called about 8:40 AM 7/17/07. Stated child had a measle-like rash on lower abdomen and groin area. C/O of some itching. Denied any other problems at this time. Discussed taking some Benadryl or using "Caladryl" lotion. She called back in about 10 min. stating child's lips were swelling had had whelps on upper chest. Denied SOB but stated he was coughing some. Told her to give him some Benadryl. Advised her to take to PMD or take to nearest ER. Took child to doctor this morning. Stated by the time the doctor saw child the rash was almost gone and lips were not as swollen. GM stated that the doctor didn't know if this was food allergy - reaction to shots or combination of both. Doctor gave him medicine but GM doesn't know the name. I tried several times to speak with nurse at doctors office but have been unsuccessful. 7-18-07 and 7-19-07 I spoke with child's grandmother and she stated child was fine.
Pt was vaccinated on 3/31/2021. His long time partner reported that he started feeling a little off 2 days post vaccination, he thought he had indigestion. Over the next few weeks he began feeling worse especially with exertion.  While at work on 4/19/2021 he told his friend that he hadn't been feeling well for 3 weeks. Shortly after reporting this he went into Cardiac arrest. He was transported to Medical Center, where he was pronounced dead. His partner reports he was healthy with the exception of hypertension. She reports he was thin, never smoked, didn't drink alcohol and rarely used marijuana.  She reports only a visual autopsy was performed and pt was cremated.
Patient came in for a well child check. Two vaccines were ordered influenza and hepatitis A, vaccines were verified with provider. Vaccines were administered subcutaneously instead of intramuscularly. Patient had immediate swelling and redness, developed pain and limping a few hours later. Patient followed up with primary care 5/17 (a few days later) was still limping and complaining of pain and fever. Provider recommended supportive care.
dizziness/very dizzy, every day; back was hurting; could not walk properly; fallen a lot; arm and leg were hurting/hurting for a few days; body was aching; body feels very weak/weak legs; dry eyes; nostrils hurt; arms was swollen; Bruised; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness/very dizzy, every day), DRY EYE (dry eyes), NASAL DISCOMFORT (nostrils hurt), PERIPHERAL SWELLING (arms was swollen) and CONTUSION (Bruised) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. OTIC21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Janssen (Patient received 1 dose of the Janssen vaccine on 13MAR2021 (lot number 1805018)) on 13-Mar-2021. Past adverse reactions to the above products included No adverse event with Janssen.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Nov-2021, the patient experienced DRY EYE (dry eyes), NASAL DISCOMFORT (nostrils hurt), PERIPHERAL SWELLING (arms was swollen) and CONTUSION (Bruised). On an unknown date, the patient experienced DIZZINESS (dizziness/very dizzy, every day), BACK PAIN (back was hurting), GAIT DISTURBANCE (could not walk properly), FALL (fallen a lot), PAIN IN EXTREMITY (arm and leg were hurting/hurting for a few days), PAIN (body was aching) and ASTHENIA (body feels very weak/weak legs). The patient was treated with PARACETAMOL (TYLENOL A) for Dizziness, at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness/very dizzy, every day) had not resolved, DRY EYE (dry eyes), NASAL DISCOMFORT (nostrils hurt), PERIPHERAL SWELLING (arms was swollen), CONTUSION (Bruised), BACK PAIN (back was hurting), GAIT DISTURBANCE (could not walk properly), FALL (fallen a lot), PAIN IN EXTREMITY (arm and leg were hurting/hurting for a few days) and PAIN (body was aching) outcome was unknown and ASTHENIA (body feels very weak/weak legs) had resolved.            No Concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Nov-2021: non signi follow-up appended(MOD21-167761- was an initial Document, but the case was created from Followup doc (MOD21-167786) so the version (MOD21-167761) was made as Non signi follow up)
Patient was coming on 6/5/2021 to get his Pfizer 2nd dose and it was a week earlier than his due date.  He was trying to get it earlier because his sister happened to be getting her Pfizer 1st dose at our location so the parents wanted him to get his 2nd dose as well.  However, they didn't tell the vacinator  (pharmacist intern).  Vaccinator thought he was due and that was why he showed up.  After vaccinated for patient, He started writing on the card and realized it was a week earlier.  He spoke to patient's parents about that patient got it 1 weeks earlier than his due date.  Parents and the patient said "it's fine.  Thank you"  He told patient to wait for 30 minutes for observance instead of the normal 15 minutes.  After the 30 minutes was up, patient was fine with no adverse event. He told the parents to call pharmacy if they have any questions or the patient felt any abnormal side effects than his first dose.  On 6/7/2021, we followed up with patient's dad to see if the patient was fine and he confirmed that the patients is normal.
Pt was given the varicella vax on 2/14/00. Parents reported a rash and low grade fever on 3/4/00. Pt in clinic on 3/8/00, dx with mild varicella.
Injection site, warm but not that painful when touched; Injection site, red and itching like there is no tomorrow; Headache; Injection site, red and itching like there is no tomorrow; Swelling on the injection site about a quarter of an inch; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site, warm but not that painful when touched), VACCINATION SITE PRURITUS (Injection site, red and itching like there is no tomorrow), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Injection site, red and itching like there is no tomorrow) and VACCINATION SITE SWELLING (Swelling on the injection site about a quarter of an inch) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023C21A and 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included RAMIPRIL (TENAPRIL) for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-May-2021, the patient experienced VACCINATION SITE WARMTH (Injection site, warm but not that painful when touched), VACCINATION SITE PRURITUS (Injection site, red and itching like there is no tomorrow), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Injection site, red and itching like there is no tomorrow), VACCINATION SITE SWELLING (Swelling on the injection site about a quarter of an inch) and PYREXIA (Slight fever). At the time of the report, VACCINATION SITE WARMTH (Injection site, warm but not that painful when touched), VACCINATION SITE PRURITUS (Injection site, red and itching like there is no tomorrow), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Injection site, red and itching like there is no tomorrow), VACCINATION SITE SWELLING (Swelling on the injection site about a quarter of an inch) and PYREXIA (Slight fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were reported.  The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable   This case was linked to MOD-2021-119154 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Email address provided and correction in patient name
Red rash at injection site approximately 3-4 inches circle-fading for 5 days.  On and off itch-5 days.   On and off slight dizziness-5 days.  Headache-first evening of rash.
Severe chills, sweating, nausea, dizziness, headache, near syncope event
Rash, c. 3.75cm in diameter, mildly itchy, became noticeable about 2 weeks after injection. Quite tolerable, no treatment given. Am reporting only to inform statistics, etc.
symptoms of flu like illness; This is a spontaneous report from a non-contactable nurse (patient). A patient of unspecified age and gender received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on unspecified date at a single dose for COVID-19 immunisation. The patient's medical history included having symptoms of covid infection. Concomitant medications were not reported. Patient received covid vaccine 14 days after having symptoms of covid infection. Patient reported significant symptoms of flu like illness for 48 hours after first dose. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
pt recv vax 27NOV95 & 28NOV95 pt noticed hives on eyelids;29NOV95 morning eyes were swollen & there was a rash on eyelids;hives also appeared on back, shoulder, & arm;MD felt rxn was poss allerg rxn;nurse felt was rxn to preservative in vax
Nausea and vomiting times one incident about 10:30PM 9-22-17. Arm red, swollen, and painful down to forearm continuing until present.